350 related articles for article (PubMed ID: 25265912)
1. The development of immunoconjugates for targeted cancer therapy.
Smaglo BG; Aldeghaither D; Weiner LM
Nat Rev Clin Oncol; 2014 Nov; 11(11):637-48. PubMed ID: 25265912
[TBL] [Abstract][Full Text] [Related]
2. Targeted drug delivery using immunoconjugates: principles and applications.
Pasquetto MV; Vecchia L; Covini D; Digilio R; Scotti C
J Immunother; 2011; 34(9):611-28. PubMed ID: 21989410
[TBL] [Abstract][Full Text] [Related]
3. Arming antibodies: prospects and challenges for immunoconjugates.
Wu AM; Senter PD
Nat Biotechnol; 2005 Sep; 23(9):1137-46. PubMed ID: 16151407
[TBL] [Abstract][Full Text] [Related]
4. CD30-targeting immunoconjugates and bystander effects.
Masuda S; Miyagawa S; Sougawa N; Sawa Y
Nat Rev Clin Oncol; 2015 Apr; 12(4):. PubMed ID: 25734636
[No Abstract] [Full Text] [Related]
5. Targeted therapy of cancer: new prospects for antibodies and immunoconjugates.
Sharkey RM; Goldenberg DM
CA Cancer J Clin; 2006; 56(4):226-43. PubMed ID: 16870998
[TBL] [Abstract][Full Text] [Related]
6. Recombinant antibodies: from the laboratory to the clinic.
Albrecht H; DeNardo SJ
Cancer Biother Radiopharm; 2006 Aug; 21(4):285-304. PubMed ID: 16999595
[TBL] [Abstract][Full Text] [Related]
7. Technology insight: cytotoxic drug immunoconjugates for cancer therapy.
Ricart AD; Tolcher AW
Nat Clin Pract Oncol; 2007 Apr; 4(4):245-55. PubMed ID: 17392715
[TBL] [Abstract][Full Text] [Related]
8. Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy.
Brumlik MJ; Daniel BJ; Waehler R; Curiel DT; Giles FJ; Curiel TJ
Expert Opin Drug Deliv; 2008 Jan; 5(1):87-103. PubMed ID: 18095930
[TBL] [Abstract][Full Text] [Related]
9. Antibody-drug conjugates: an emerging modality for the treatment of cancer.
Leal M; Sapra P; Hurvitz SA; Senter P; Wahl A; Schutten M; Shah DK; Haddish-Berhane N; Kabbarah O
Ann N Y Acad Sci; 2014 Aug; 1321():41-54. PubMed ID: 25123209
[TBL] [Abstract][Full Text] [Related]
10. Meeting report on the Ninth Conference on Cancer Therapy with Antibodies and Immunoconjugates.
Sharkey RM; Sausville EA; Goldenberg DM
Cancer Res; 2003 Nov; 63(22):8069-71. PubMed ID: 14633741
[TBL] [Abstract][Full Text] [Related]
11. Trends in cancer-targeted antibody-drug conjugates.
Bidard FC; Trédan O
Target Oncol; 2014 Mar; 9(1):1-8. PubMed ID: 24221961
[TBL] [Abstract][Full Text] [Related]
12. Abstracts from the Eleventh Conference on Cancer Therapy with Antibodies and Immunoconjugates. October 12-14, 2006. Parsippany, New Jersey, USA.
Cancer Biother Radiopharm; 2006 Aug; 21(4):382-405. PubMed ID: 16999603
[No Abstract] [Full Text] [Related]
13. Antibody drug conjugates: Progress, pitfalls, and promises.
Mukherjee A; Waters AK; Babic I; Nurmemmedov E; Glassy MC; Kesari S; Yenugonda VM
Hum Antibodies; 2019; 27(1):53-62. PubMed ID: 30223393
[TBL] [Abstract][Full Text] [Related]
14. Bispecific antibodies and ADCs: Once and future kings?
Reichert JM
MAbs; 2011; 3(4):329-30. PubMed ID: 21654205
[No Abstract] [Full Text] [Related]
15. Targeted Therapy With Immunoconjugates for Multiple Myeloma.
Bruins WSC; Zweegman S; Mutis T; van de Donk NWCJ
Front Immunol; 2020; 11():1155. PubMed ID: 32636838
[TBL] [Abstract][Full Text] [Related]
16. Advances in the treatment of hematologic malignancies using immunoconjugates.
Palanca-Wessels MC; Press OW
Blood; 2014 Apr; 123(15):2293-301. PubMed ID: 24578502
[TBL] [Abstract][Full Text] [Related]
17. Antibody delivery of drugs and radionuclides: factors influencing clinical pharmacology.
Prabhu S; Boswell CA; Leipold D; Khawli LA; Li D; Lu D; Theil FP; Joshi A; Lum BL
Ther Deliv; 2011 Jun; 2(6):769-91. PubMed ID: 22822508
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Advances in Oncology.
Liu J; Pandya P; Afshar S
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670524
[TBL] [Abstract][Full Text] [Related]
19. Antibody-cytokine fusion proteins.
Kontermann RE
Arch Biochem Biophys; 2012 Oct; 526(2):194-205. PubMed ID: 22445675
[TBL] [Abstract][Full Text] [Related]
20. Tumour-targeted chemotherapy with immunoconjugates of calicheamicin.
Damle NK
Expert Opin Biol Ther; 2004 Sep; 4(9):1445-52. PubMed ID: 15335312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
